Paranovus Entertainment Technology Return on Equity

The latest ROE for PAVS is -32.6%. That is below the Healthcare sector average of 22.76%. Investors often review this figure alongside Paranovus Entertainment Technology's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, PAVS currently prints -32.6% for ROE, while the sector average sits near 22.76%. That is roughly 243.2% below the sector mean. Large gaps often invite a closer look at Paranovus Entertainment Technology's growth, margins, and balance sheet.

Return on Equity shows how effectively Paranovus Entertainment Technology converts resources into returns. At -32.6%, PAVS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PAVS's ROE (-32.6%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Paranovus Entertainment Technology's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.